Precision Risk Stratification in Hepatocellular Carcinoma: Clinical Relevance of CatBoost-based Prediction Following TACE. Rouzbahani M. Radiol Imaging Cancer 2025;7:e250386.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rouzbahani M. Precision Risk Stratification in Hepatocellular Carcinoma: Clinical Relevance of CatBoost-based Prediction Following TACE. Radiol Imaging Cancer 2025;7:e250386.
PMID: 40910881